Chinese AI beats 15 doctors in tumor diagnosis competition

July 3, 2018

An AI system has wiped the floor with some of China’s top doctors when it comes to diagnosing brain tumors and predicting hematoma expansion.

As reported by Xinhua, the system defeated a team comprised of 15 of China’s top doctors by a margin of two to one. The AI, BioMind, was developed by the Artificial Intelligence Research Centre for Neurological Disorders at Beijing Tiantan Hospital, and is another example of the long line of the technology analyzing images.

When diagnosing brain tumors, BioMind was correct 87% of the time, compared to 66% by the medical professionals. The AI also only took 15 minutes to diagnose the 225 cases, while doctors took 30.

In regard to predicting brain hematoma expansion, BioMind was victorious again, as it was correct in 83% of cases, with humans managing only 63%.

Researchers trained the AI by feeding it thousands upon thousands of images from Beijing Tiantan Hospital’s archives. This has made it as good at diagnosing neurological diseases as senior doctors, as it has a 90% accuracy rate.

The executive vice-president of Beijing Tiantan Hospital, Wang Yongjun, told Xinhua that he didn’t care who won in the battle between doctors and the AI.

“I hope through this competition, doctors can experience the power of artificial intelligence,” he said. “This is especially so for some doctors who are skeptical about artificial intelligence. I hope they can further understand AI and eliminate their fears toward it.”

The Next Web has the story

Sponsored Recommendations

ASK THE EXPERT: ServiceNow’s Erin Smithouser on what C-suite healthcare executives need to know about artificial intelligence

Generative artificial intelligence, also known as GenAI, learns from vast amounts of existing data and large language models to help healthcare organizations improve hospital ...

TEST: Ask the Expert: Is Your Patients' Understanding Putting You at Risk?

Effective health literacy in healthcare is essential for ensuring informed consent, reducing medical malpractice risks, and enhancing patient-provider communication. Unfortunately...

From Strategy to Action: The Power of Enterprise Value-Based Care

Ever wonder why your meticulously planned value-based care model hasn't moved beyond the concept stage? You're not alone! Transition from theory to practice with enterprise value...

State of the Market: Transforming Healthcare; Strategies for Building a Resilient and Adaptive Workforce

The U.S. healthcare system is facing critical challenges, including workforce shortages, high turnover, and regulatory pressures. This guide highlights the vital role of technology...